What is the recommended prednisone dosing regimen (initial dose, duration, and taper) for an adult with an acute gout flare, especially in elderly patients or those with diabetes, hypertension, or peptic ulcer disease?

Prednisone Dosing for Acute Gout

For acute gout flares, prescribe prednisone 30–50 mg daily (or prednisolone 35 mg daily) for 5 days without a taper, or alternatively use an initial dose of 30–50 mg daily followed by a gradual taper over 7–10 days. 1

First-Line Recommendation

The American College of Physicians (2017) strongly recommends oral corticosteroids as the preferred first-line pharmacologic option for acute gout based on high-quality evidence showing equivalent efficacy to NSAIDs but with a superior safety profile. 2, 1

Specific Dosing Regimens

Standard 5-Day Course (Preferred)

• Prednisolone 35 mg once daily for 5 days (no taper required) achieves complete symptom resolution in most patients without rebound arthropathy. 1, 3
• This regimen is equivalent to prednisone 35 mg daily for 5 days, as the dosage range is the same for both agents. 4

Alternative Tapered Regimen

• Prednisone 30–50 mg daily initially, then gradually taper over 7–10 days is an acceptable alternative when a longer course is clinically preferred. 1, 5
• The FDA label indicates initial dosing may range from 5–60 mg per day depending on disease severity, with gradual withdrawal recommended after long-term therapy. 4

Timing of Administration

• Administer prednisone in the morning prior to 9 AM to minimize suppression of adrenocortical activity. 4
• Take with food or milk to reduce gastric irritation. 4

Efficacy Evidence

• A high-quality randomized equivalence trial (n=120) demonstrated that prednisolone 35 mg daily for 5 days produced pain reduction equivalent to naproxen 500 mg twice daily (44.7 mm vs 46.0 mm on a 100-mm visual analogue scale after 90 hours, difference 1.3 mm). 3
• A larger multicenter trial (n=416) confirmed equivalent analgesic effectiveness between oral prednisolone and indomethacin, with clinically significant within-group reductions in pain scores of approximately 25 mm at rest and 45 mm with activity over 14 days. 6

Special Populations & Comorbidities

Chronic Kidney Disease (Stage ≥3)

• Corticosteroids are strongly preferred over NSAIDs, which are contraindicated in renal impairment. 1
• Short-term corticosteroids carry minimal renal risk. 1

Diabetes Mellitus

• A 5-day prednisone course may cause transient hyperglycemia, which is generally manageable with temporary adjustments to diabetes medications. 1
• Monitor blood glucose more frequently during treatment. 4

Hypertension

• Mild, short-lived fluid retention and modest blood pressure elevation can occur but rarely require therapeutic intervention. 1
• Dietary salt restriction may be advisable. 4

Peptic Ulcer Disease or GI Bleeding History

• Corticosteroids have a more favorable GI safety profile than NSAIDs for short-term use in acute gout. 1
• NSAIDs markedly increase bleeding risk and are contraindicated in active or prior GI bleeding. 1
• Routine PPI prophylaxis with short-term corticosteroids (5 days) is not necessary unless other high-risk factors are present. 7
• When large doses are given for longer durations, consider antacids between meals. 4

Congestive Heart Failure

• Corticosteroids avoid the fluid retention and cardiovascular worsening associated with NSAIDs. 1

Cirrhosis

• NSAIDs are contraindicated; corticosteroids are safer for short-term use. 1

Elderly Patients

• Start at the low end of the dosing range (30 mg daily rather than 50 mg). 4
• Monitor for increased risk of diabetes, fluid retention, and hypertension. 4

Treatment Algorithm

1. First choice: Prednisone/prednisolone 35 mg daily for 5 days (or 30–50 mg daily with 7–10 day taper). 1

2. If corticosteroids are contraindicated: Use full-dose NSAID (e.g., naproxen 500 mg twice daily or indomethacin 50 mg three times daily). 1

3. If both corticosteroids and NSAIDs are contraindicated: Low-dose colchicine (1.2 mg loading dose followed by 0.6 mg one hour later), provided treatment starts within 36 hours of symptom onset. 2, 1

Contraindications to Corticosteroids

• Systemic fungal infections (absolute contraindication). 1
• Known hypersensitivity to corticosteroids. 1
• Active, untreated infections require careful risk-benefit assessment. 1

Common Pitfalls

• Avoid abrupt withdrawal after courses longer than 5–10 days; taper gradually. 4
• Do not use high-dose colchicine regimens (e.g., 0.6 mg every hour for several hours), which cause severe GI toxicity without added efficacy. 2, 1
• Continue therapy at full dose until the acute attack completely resolves (typically 7–14 days), not just until symptoms improve. 1
• When prescribing for longer than 5 days, monitor for hyperglycemia, hypertension, and fluid retention, especially in at-risk populations. 4

Adverse Effects of Short-Term Use

• Minor, self-limited adverse events with 5-day courses include transient hyperglycemia, mild fluid retention, mood changes (uncommon), and GI discomfort (less frequent than with NSAIDs). 1
• A large trial showed fewer minor adverse events with prednisolone versus indomethacin during the ED phase (6% vs 19%, P<0.001), with similar rates (37% each group) over 14 days. 6